Theriva Biologics Inc. (TOVX) — Cash Flow-to-Debt Ratio
Theriva Biologics Inc. (TOVX) has a Cash Flow-to-Debt Ratio of -0.11x as of March 2026, meaning its operating cash flow of $-2.46 Million could theoretically repay 0% of its total liabilities ($22.85 Million) in one year. Check Theriva Biologics Inc. (TOVX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Theriva Biologics Inc. Cash Flow-to-Debt Ratio (1993–2025)
Historical debt coverage capacity for Theriva Biologics Inc. across 31 annual periods. Also explore TOVX asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Theriva Biologics Inc. (1993–2025)
Year-by-year debt coverage analysis for Theriva Biologics Inc.. For market capitalisation and broader financial context, see how much is Theriva Biologics Inc. worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.73x | $-16.67 Million | $22.86 Million | ▲ +29.9% |
| 2024 | -1.04x | $-16.94 Million | $16.29 Million | ▲ +15.0% |
| 2023 | -1.22x | $-19.00 Million | $15.52 Million | ▼ -10.9% |
| 2022 | -1.10x | $-19.08 Million | $17.30 Million | ▲ +57.6% |
| 2021 | -2.60x | $-12.89 Million | $4.96 Million | ▲ +32.6% |
| 2020 | -3.86x | $-12.17 Million | $3.15 Million | ▼ -59.9% |
| 2019 | -2.41x | $-13.87 Million | $5.75 Million | ▲ +48.5% |
| 2018 | -4.69x | $-17.28 Million | $3.69 Million | ▼ -416.2% |
| 2017 | -0.91x | $-20.20 Million | $22.25 Million | ▲ +34.1% |
| 2016 | -1.38x | $-27.90 Million | $20.25 Million | ▲ +43.9% |
| 2015 | -2.45x | $-38.89 Million | $15.84 Million | ▼ -46.4% |
| 2014 | -1.68x | $-16.08 Million | $9.59 Million | ▲ +77.7% |
| 2013 | -7.52x | $-7.72 Million | $1.03 Million | ▲ +66.7% |
| 2012 | -22.57x | $-8.92 Million | $395.00K | ▼ -227.4% |
| 2011 | -6.89x | $-2.88 Million | $417.00K | ▼ -222.1% |
| 2010 | -2.14x | $-1.14 Million | $532.48K | ▲ +61.0% |
| 2009 | -5.49x | $-2.92 Million | $531.43K | ▲ +29.7% |
| 2008 | -7.82x | $-4.85 Million | $620.72K | ▼ -99.6% |
| 2007 | -3.92x | $-6.61 Million | $1.69 Million | ▼ -20.6% |
| 2006 | -3.25x | $-2.37 Million | $729.02K | ▼ -542.9% |
| 2005 | -0.50x | $-1.08 Million | $2.14 Million | ▼ -46.5% |
| 2002 | -0.34x | $-5.82 Million | $16.90 Million | ▲ +52.4% |
| 2001 | -0.72x | $-8.07 Million | $11.14 Million | ▲ +24.8% |
| 2000 | -0.96x | $-5.65 Million | $5.86 Million | ▲ +73.9% |
| 1999 | -3.69x | $-16.14 Million | $4.38 Million | ▲ +56.6% |
| 1998 | -8.50x | $-18.70 Million | $2.20 Million | ▼ -267.9% |
| 1997 | -2.31x | $-6.70 Million | $2.90 Million | ▲ +57.6% |
| 1996 | -5.45x | $-6.00 Million | $1.10 Million | ▲ +70.9% |
| 1995 | -18.75x | $-7.50 Million | $400.00K | ▼ -275.0% |
| 1994 | -5.00x | $-4.50 Million | $900.00K | ▲ +71.4% |
| 1993 | -17.50x | $-3.50 Million | $200.00K | — |